FDA Releases Draft Guidance on Ethical Considerations for Clinical Investigations Involving Children

Summary

The Food and Drug Administration (FDA) has published a draft guidance document outlining its ethical considerations for clinical trials involving children, aiming to help industry, sponsors, and Institutional Review Boards make informed decisions about enrolling children in these trials.